Square Pharmaceuticals PLC. has informed that the Board of Directors in its meeting held on July 12, 2023 has approved an agreement with M/s Aristopharma Ltd. for contract manufacturing of some products on behalf of the company to meet increased demand of existing products and to introduce new products.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
210.9 BDT | +1.39% | -0.85% | +0.29% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.29% | 1.7B | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- SQURPHARMA Stock
- News Square Pharmaceuticals PLC.
- Square Pharmaceuticals PLC Announces Contract Manufacturing Agreement with M/S Aristopharma Ltd